SLC6A3 and Parkinson disease: In the three-year follow-up study of the same cohort, no loss of DAT uptake was reported but ET patients continued to exhibit a predominant impairment of DAT in the caudate, suggesting the selective dopaminergic loss in the caudate nucleus as a possible pathophysiological link with PD.